CELLULAR SIGNALLING-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2166615, encodeId=9c21216661581, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：从投稿到接收一个月零一周效率很高了。两周返回一审意见十天修回修回后两周接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Sat Nov 04 09:45:15 CST 2023, time=2023-11-04, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=584206, encodeId=9141584206fc, content=您好，这个杂志提交文章时需要上传原始数据吗 田田要学习 2019-11-17 发表:: 投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…田田要学习 2019-11-17 00:00:00 发表: 投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…, beContent=田田要学习 2019-11-17 发表:: 投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79075262635, createdName=1480676am48(暂无昵称), createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129105, encodeId=4d6a212910559, content=请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Fri Apr 28 20:58:27 CST 2023, time=2023-04-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=964554, encodeId=29fa9645544c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：一审40多天，返回大修；1个月后修回，送审1周多返回小修(一个很小的点)；二次修回又送审了，现在2周了，系统显著审稿结束1周多(Required Reviews Completed)，还没消息。感觉编辑处理速度比较慢，也没有像别人说的那样修回一两天就接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0765497914, createdName=牛奶味的果汁, createdTime=Tue May 11 12:47:36 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145528, encodeId=bbb0214552839, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：癌症;LncRNA;机制研究 经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e68203665, createdName=ms3000001479435505, createdTime=Thu Jun 29 21:02:28 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2093349, encodeId=4e632093349e1, content=请问一般with editor多久啊？都一周了还没有消息？会不会被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b058356108, createdName=ms1000000391690108, createdTime=Wed Oct 12 11:14:27 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095327, encodeId=7456209532ef1, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：生物信息学 经验分享：很好的投稿体验！主要是做公共单细胞数据库挖掘+不到1个figure的湿实验（组化+免疫荧光），审稿速度超快，9-18左右投稿，一周左右就送审了，10-8左右给的一审意见，隔了三天修回，第二天就给二审意见，补充了一个组化，10-20左右修回，10-22今天早上看就已经accept！祝大家投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da05572124, createdName=ms2000000321618143, createdTime=Sat Oct 22 09:29:14 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147806, encodeId=005b214e806e4, content=偏重的研究方向：心血管疾病 经验分享：这个杂志是不是 submit to the journal后立即就under review了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Thu Jul 13 10:13:14 CST 2023, time=2023-07-13, status=1, ipAttribution=首尔), GetPortalCommentsPageByObjectIdResponse(id=2128354, encodeId=f3c1212835411, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;信号通路 经验分享：这个期刊效率挺高的，3月4号投稿，29号收到小修意见，4月10号修回，4月23号接收。总体而言，投稿体验不错，效率快，审稿人和编辑也很n i c e。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd698523082, createdName=ms4000000431284905, createdTime=Wed Apr 26 01:20:31 CST 2023, time=2023-04-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2153895, encodeId=19632153895ba, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：耐药 经验分享：新鲜出炉的投稿数据分享： 6-20投稿， 6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修 8-08修回 8-21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Aug 21 17:00:18 CST 2023, time=2023-08-21, status=1, ipAttribution=广东省)]

2023-11-04 ms7000000431018817 来自天津

审稿速度:1.0 | 投稿命中率:75.0
经验分享：从投稿到接收一个月零一周效率很高了。两周返回一审意见十天修回修回后两周接收

45 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166615, encodeId=9c21216661581, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：从投稿到接收一个月零一周效率很高了。两周返回一审意见十天修回修回后两周接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Sat Nov 04 09:45:15 CST 2023, time=2023-11-04, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=584206, encodeId=9141584206fc, content=您好，这个杂志提交文章时需要上传原始数据吗 田田要学习 2019-11-17 发表:: 投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…田田要学习 2019-11-17 00:00:00 发表: 投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…, beContent=田田要学习 2019-11-17 发表:: 投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79075262635, createdName=1480676am48(暂无昵称), createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129105, encodeId=4d6a212910559, content=请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Fri Apr 28 20:58:27 CST 2023, time=2023-04-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=964554, encodeId=29fa9645544c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：一审40多天，返回大修；1个月后修回，送审1周多返回小修(一个很小的点)；二次修回又送审了，现在2周了，系统显著审稿结束1周多(Required Reviews Completed)，还没消息。感觉编辑处理速度比较慢，也没有像别人说的那样修回一两天就接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0765497914, createdName=牛奶味的果汁, createdTime=Tue May 11 12:47:36 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145528, encodeId=bbb0214552839, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：癌症;LncRNA;机制研究 经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e68203665, createdName=ms3000001479435505, createdTime=Thu Jun 29 21:02:28 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2093349, encodeId=4e632093349e1, content=请问一般with editor多久啊？都一周了还没有消息？会不会被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b058356108, createdName=ms1000000391690108, createdTime=Wed Oct 12 11:14:27 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095327, encodeId=7456209532ef1, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：生物信息学 经验分享：很好的投稿体验！主要是做公共单细胞数据库挖掘+不到1个figure的湿实验（组化+免疫荧光），审稿速度超快，9-18左右投稿，一周左右就送审了，10-8左右给的一审意见，隔了三天修回，第二天就给二审意见，补充了一个组化，10-20左右修回，10-22今天早上看就已经accept！祝大家投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da05572124, createdName=ms2000000321618143, createdTime=Sat Oct 22 09:29:14 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147806, encodeId=005b214e806e4, content=偏重的研究方向：心血管疾病 经验分享：这个杂志是不是 submit to the journal后立即就under review了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Thu Jul 13 10:13:14 CST 2023, time=2023-07-13, status=1, ipAttribution=首尔), GetPortalCommentsPageByObjectIdResponse(id=2128354, encodeId=f3c1212835411, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;信号通路 经验分享：这个期刊效率挺高的，3月4号投稿，29号收到小修意见，4月10号修回，4月23号接收。总体而言，投稿体验不错，效率快，审稿人和编辑也很n i c e。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd698523082, createdName=ms4000000431284905, createdTime=Wed Apr 26 01:20:31 CST 2023, time=2023-04-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2153895, encodeId=19632153895ba, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：耐药 经验分享：新鲜出炉的投稿数据分享： 6-20投稿， 6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修 8-08修回 8-21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Aug 21 17:00:18 CST 2023, time=2023-08-21, status=1, ipAttribution=广东省)]

2020-02-04 1480676am48(暂无昵称)

您好，这个杂志提交文章时需要上传原始数据吗田田要学习 2019-11-17 发表::
投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…田田要学习 2019-11-17 00:00:00 发表:
投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…

田田要学习 2019-11-17 发表:: 投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…

174 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166615, encodeId=9c21216661581, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：从投稿到接收一个月零一周效率很高了。两周返回一审意见十天修回修回后两周接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Sat Nov 04 09:45:15 CST 2023, time=2023-11-04, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=584206, encodeId=9141584206fc, content=您好，这个杂志提交文章时需要上传原始数据吗 田田要学习 2019-11-17 发表:: 投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…田田要学习 2019-11-17 00:00:00 发表: 投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…, beContent=田田要学习 2019-11-17 发表:: 投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79075262635, createdName=1480676am48(暂无昵称), createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129105, encodeId=4d6a212910559, content=请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Fri Apr 28 20:58:27 CST 2023, time=2023-04-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=964554, encodeId=29fa9645544c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：一审40多天，返回大修；1个月后修回，送审1周多返回小修(一个很小的点)；二次修回又送审了，现在2周了，系统显著审稿结束1周多(Required Reviews Completed)，还没消息。感觉编辑处理速度比较慢，也没有像别人说的那样修回一两天就接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0765497914, createdName=牛奶味的果汁, createdTime=Tue May 11 12:47:36 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145528, encodeId=bbb0214552839, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：癌症;LncRNA;机制研究 经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e68203665, createdName=ms3000001479435505, createdTime=Thu Jun 29 21:02:28 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2093349, encodeId=4e632093349e1, content=请问一般with editor多久啊？都一周了还没有消息？会不会被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b058356108, createdName=ms1000000391690108, createdTime=Wed Oct 12 11:14:27 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095327, encodeId=7456209532ef1, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：生物信息学 经验分享：很好的投稿体验！主要是做公共单细胞数据库挖掘+不到1个figure的湿实验（组化+免疫荧光），审稿速度超快，9-18左右投稿，一周左右就送审了，10-8左右给的一审意见，隔了三天修回，第二天就给二审意见，补充了一个组化，10-20左右修回，10-22今天早上看就已经accept！祝大家投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da05572124, createdName=ms2000000321618143, createdTime=Sat Oct 22 09:29:14 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147806, encodeId=005b214e806e4, content=偏重的研究方向：心血管疾病 经验分享：这个杂志是不是 submit to the journal后立即就under review了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Thu Jul 13 10:13:14 CST 2023, time=2023-07-13, status=1, ipAttribution=首尔), GetPortalCommentsPageByObjectIdResponse(id=2128354, encodeId=f3c1212835411, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;信号通路 经验分享：这个期刊效率挺高的，3月4号投稿，29号收到小修意见，4月10号修回，4月23号接收。总体而言，投稿体验不错，效率快，审稿人和编辑也很n i c e。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd698523082, createdName=ms4000000431284905, createdTime=Wed Apr 26 01:20:31 CST 2023, time=2023-04-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2153895, encodeId=19632153895ba, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：耐药 经验分享：新鲜出炉的投稿数据分享： 6-20投稿， 6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修 8-08修回 8-21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Aug 21 17:00:18 CST 2023, time=2023-08-21, status=1, ipAttribution=广东省)]

2023-04-28 ms1000000465565248 来自江苏省

请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？

47 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166615, encodeId=9c21216661581, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：从投稿到接收一个月零一周效率很高了。两周返回一审意见十天修回修回后两周接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Sat Nov 04 09:45:15 CST 2023, time=2023-11-04, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=584206, encodeId=9141584206fc, content=您好，这个杂志提交文章时需要上传原始数据吗 田田要学习 2019-11-17 发表:: 投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…田田要学习 2019-11-17 00:00:00 发表: 投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…, beContent=田田要学习 2019-11-17 发表:: 投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79075262635, createdName=1480676am48(暂无昵称), createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129105, encodeId=4d6a212910559, content=请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Fri Apr 28 20:58:27 CST 2023, time=2023-04-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=964554, encodeId=29fa9645544c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：一审40多天，返回大修；1个月后修回，送审1周多返回小修(一个很小的点)；二次修回又送审了，现在2周了，系统显著审稿结束1周多(Required Reviews Completed)，还没消息。感觉编辑处理速度比较慢，也没有像别人说的那样修回一两天就接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0765497914, createdName=牛奶味的果汁, createdTime=Tue May 11 12:47:36 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145528, encodeId=bbb0214552839, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：癌症;LncRNA;机制研究 经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e68203665, createdName=ms3000001479435505, createdTime=Thu Jun 29 21:02:28 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2093349, encodeId=4e632093349e1, content=请问一般with editor多久啊？都一周了还没有消息？会不会被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b058356108, createdName=ms1000000391690108, createdTime=Wed Oct 12 11:14:27 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095327, encodeId=7456209532ef1, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：生物信息学 经验分享：很好的投稿体验！主要是做公共单细胞数据库挖掘+不到1个figure的湿实验（组化+免疫荧光），审稿速度超快，9-18左右投稿，一周左右就送审了，10-8左右给的一审意见，隔了三天修回，第二天就给二审意见，补充了一个组化，10-20左右修回，10-22今天早上看就已经accept！祝大家投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da05572124, createdName=ms2000000321618143, createdTime=Sat Oct 22 09:29:14 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147806, encodeId=005b214e806e4, content=偏重的研究方向：心血管疾病 经验分享：这个杂志是不是 submit to the journal后立即就under review了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Thu Jul 13 10:13:14 CST 2023, time=2023-07-13, status=1, ipAttribution=首尔), GetPortalCommentsPageByObjectIdResponse(id=2128354, encodeId=f3c1212835411, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;信号通路 经验分享：这个期刊效率挺高的，3月4号投稿，29号收到小修意见，4月10号修回，4月23号接收。总体而言，投稿体验不错，效率快，审稿人和编辑也很n i c e。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd698523082, createdName=ms4000000431284905, createdTime=Wed Apr 26 01:20:31 CST 2023, time=2023-04-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2153895, encodeId=19632153895ba, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：耐药 经验分享：新鲜出炉的投稿数据分享： 6-20投稿， 6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修 8-08修回 8-21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Aug 21 17:00:18 CST 2023, time=2023-08-21, status=1, ipAttribution=广东省)]

2021-05-11 牛奶味的果汁

审稿速度:2.0 | 投稿命中率:75.0
经验分享：一审40多天，返回大修；1个月后修回，送审1周多返回小修(一个很小的点)；二次修回又送审了，现在2周了，系统显著审稿结束1周多(Required Reviews Completed)，还没消息。感觉编辑处理速度比较慢，也没有像别人说的那样修回一两天就接收了

80 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166615, encodeId=9c21216661581, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：从投稿到接收一个月零一周效率很高了。两周返回一审意见十天修回修回后两周接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Sat Nov 04 09:45:15 CST 2023, time=2023-11-04, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=584206, encodeId=9141584206fc, content=您好，这个杂志提交文章时需要上传原始数据吗 田田要学习 2019-11-17 发表:: 投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…田田要学习 2019-11-17 00:00:00 发表: 投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…, beContent=田田要学习 2019-11-17 发表:: 投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79075262635, createdName=1480676am48(暂无昵称), createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129105, encodeId=4d6a212910559, content=请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Fri Apr 28 20:58:27 CST 2023, time=2023-04-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=964554, encodeId=29fa9645544c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：一审40多天，返回大修；1个月后修回，送审1周多返回小修(一个很小的点)；二次修回又送审了，现在2周了，系统显著审稿结束1周多(Required Reviews Completed)，还没消息。感觉编辑处理速度比较慢，也没有像别人说的那样修回一两天就接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0765497914, createdName=牛奶味的果汁, createdTime=Tue May 11 12:47:36 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145528, encodeId=bbb0214552839, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：癌症;LncRNA;机制研究 经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e68203665, createdName=ms3000001479435505, createdTime=Thu Jun 29 21:02:28 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2093349, encodeId=4e632093349e1, content=请问一般with editor多久啊？都一周了还没有消息？会不会被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b058356108, createdName=ms1000000391690108, createdTime=Wed Oct 12 11:14:27 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095327, encodeId=7456209532ef1, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：生物信息学 经验分享：很好的投稿体验！主要是做公共单细胞数据库挖掘+不到1个figure的湿实验（组化+免疫荧光），审稿速度超快，9-18左右投稿，一周左右就送审了，10-8左右给的一审意见，隔了三天修回，第二天就给二审意见，补充了一个组化，10-20左右修回，10-22今天早上看就已经accept！祝大家投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da05572124, createdName=ms2000000321618143, createdTime=Sat Oct 22 09:29:14 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147806, encodeId=005b214e806e4, content=偏重的研究方向：心血管疾病 经验分享：这个杂志是不是 submit to the journal后立即就under review了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Thu Jul 13 10:13:14 CST 2023, time=2023-07-13, status=1, ipAttribution=首尔), GetPortalCommentsPageByObjectIdResponse(id=2128354, encodeId=f3c1212835411, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;信号通路 经验分享：这个期刊效率挺高的，3月4号投稿，29号收到小修意见，4月10号修回，4月23号接收。总体而言，投稿体验不错，效率快，审稿人和编辑也很n i c e。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd698523082, createdName=ms4000000431284905, createdTime=Wed Apr 26 01:20:31 CST 2023, time=2023-04-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2153895, encodeId=19632153895ba, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：耐药 经验分享：新鲜出炉的投稿数据分享： 6-20投稿， 6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修 8-08修回 8-21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Aug 21 17:00:18 CST 2023, time=2023-08-21, status=1, ipAttribution=广东省)]

2023-06-29 ms3000001479435505 来自江苏省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：癌症;LncRNA;机制研究
经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。

41 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166615, encodeId=9c21216661581, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：从投稿到接收一个月零一周效率很高了。两周返回一审意见十天修回修回后两周接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Sat Nov 04 09:45:15 CST 2023, time=2023-11-04, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=584206, encodeId=9141584206fc, content=您好，这个杂志提交文章时需要上传原始数据吗 田田要学习 2019-11-17 发表:: 投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…田田要学习 2019-11-17 00:00:00 发表: 投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…, beContent=田田要学习 2019-11-17 发表:: 投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79075262635, createdName=1480676am48(暂无昵称), createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129105, encodeId=4d6a212910559, content=请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Fri Apr 28 20:58:27 CST 2023, time=2023-04-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=964554, encodeId=29fa9645544c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：一审40多天，返回大修；1个月后修回，送审1周多返回小修(一个很小的点)；二次修回又送审了，现在2周了，系统显著审稿结束1周多(Required Reviews Completed)，还没消息。感觉编辑处理速度比较慢，也没有像别人说的那样修回一两天就接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0765497914, createdName=牛奶味的果汁, createdTime=Tue May 11 12:47:36 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145528, encodeId=bbb0214552839, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：癌症;LncRNA;机制研究 经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e68203665, createdName=ms3000001479435505, createdTime=Thu Jun 29 21:02:28 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2093349, encodeId=4e632093349e1, content=请问一般with editor多久啊？都一周了还没有消息？会不会被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b058356108, createdName=ms1000000391690108, createdTime=Wed Oct 12 11:14:27 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095327, encodeId=7456209532ef1, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：生物信息学 经验分享：很好的投稿体验！主要是做公共单细胞数据库挖掘+不到1个figure的湿实验（组化+免疫荧光），审稿速度超快，9-18左右投稿，一周左右就送审了，10-8左右给的一审意见，隔了三天修回，第二天就给二审意见，补充了一个组化，10-20左右修回，10-22今天早上看就已经accept！祝大家投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da05572124, createdName=ms2000000321618143, createdTime=Sat Oct 22 09:29:14 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147806, encodeId=005b214e806e4, content=偏重的研究方向：心血管疾病 经验分享：这个杂志是不是 submit to the journal后立即就under review了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Thu Jul 13 10:13:14 CST 2023, time=2023-07-13, status=1, ipAttribution=首尔), GetPortalCommentsPageByObjectIdResponse(id=2128354, encodeId=f3c1212835411, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;信号通路 经验分享：这个期刊效率挺高的，3月4号投稿，29号收到小修意见，4月10号修回，4月23号接收。总体而言，投稿体验不错，效率快，审稿人和编辑也很n i c e。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd698523082, createdName=ms4000000431284905, createdTime=Wed Apr 26 01:20:31 CST 2023, time=2023-04-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2153895, encodeId=19632153895ba, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：耐药 经验分享：新鲜出炉的投稿数据分享： 6-20投稿， 6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修 8-08修回 8-21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Aug 21 17:00:18 CST 2023, time=2023-08-21, status=1, ipAttribution=广东省)]

2022-10-12 ms1000000391690108

请问一般with editor多久啊？都一周了还没有消息？会不会被拒？

44 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166615, encodeId=9c21216661581, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：从投稿到接收一个月零一周效率很高了。两周返回一审意见十天修回修回后两周接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Sat Nov 04 09:45:15 CST 2023, time=2023-11-04, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=584206, encodeId=9141584206fc, content=您好，这个杂志提交文章时需要上传原始数据吗 田田要学习 2019-11-17 发表:: 投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…田田要学习 2019-11-17 00:00:00 发表: 投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…, beContent=田田要学习 2019-11-17 发表:: 投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79075262635, createdName=1480676am48(暂无昵称), createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129105, encodeId=4d6a212910559, content=请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Fri Apr 28 20:58:27 CST 2023, time=2023-04-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=964554, encodeId=29fa9645544c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：一审40多天，返回大修；1个月后修回，送审1周多返回小修(一个很小的点)；二次修回又送审了，现在2周了，系统显著审稿结束1周多(Required Reviews Completed)，还没消息。感觉编辑处理速度比较慢，也没有像别人说的那样修回一两天就接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0765497914, createdName=牛奶味的果汁, createdTime=Tue May 11 12:47:36 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145528, encodeId=bbb0214552839, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：癌症;LncRNA;机制研究 经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e68203665, createdName=ms3000001479435505, createdTime=Thu Jun 29 21:02:28 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2093349, encodeId=4e632093349e1, content=请问一般with editor多久啊？都一周了还没有消息？会不会被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b058356108, createdName=ms1000000391690108, createdTime=Wed Oct 12 11:14:27 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095327, encodeId=7456209532ef1, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：生物信息学 经验分享：很好的投稿体验！主要是做公共单细胞数据库挖掘+不到1个figure的湿实验（组化+免疫荧光），审稿速度超快，9-18左右投稿，一周左右就送审了，10-8左右给的一审意见，隔了三天修回，第二天就给二审意见，补充了一个组化，10-20左右修回，10-22今天早上看就已经accept！祝大家投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da05572124, createdName=ms2000000321618143, createdTime=Sat Oct 22 09:29:14 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147806, encodeId=005b214e806e4, content=偏重的研究方向：心血管疾病 经验分享：这个杂志是不是 submit to the journal后立即就under review了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Thu Jul 13 10:13:14 CST 2023, time=2023-07-13, status=1, ipAttribution=首尔), GetPortalCommentsPageByObjectIdResponse(id=2128354, encodeId=f3c1212835411, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;信号通路 经验分享：这个期刊效率挺高的，3月4号投稿，29号收到小修意见，4月10号修回，4月23号接收。总体而言，投稿体验不错，效率快，审稿人和编辑也很n i c e。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd698523082, createdName=ms4000000431284905, createdTime=Wed Apr 26 01:20:31 CST 2023, time=2023-04-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2153895, encodeId=19632153895ba, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：耐药 经验分享：新鲜出炉的投稿数据分享： 6-20投稿， 6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修 8-08修回 8-21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Aug 21 17:00:18 CST 2023, time=2023-08-21, status=1, ipAttribution=广东省)]

2022-10-22 ms2000000321618143

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：生物信息学
经验分享：很好的投稿体验！主要是做公共单细胞数据库挖掘+不到1个figure的湿实验（组化+免疫荧光），审稿速度超快，9-18左右投稿，一周左右就送审了，10-8左右给的一审意见，隔了三天修回，第二天就给二审意见，补充了一个组化，10-20左右修回，10-22今天早上看就已经accept！祝大家投稿顺利！

56 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166615, encodeId=9c21216661581, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：从投稿到接收一个月零一周效率很高了。两周返回一审意见十天修回修回后两周接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Sat Nov 04 09:45:15 CST 2023, time=2023-11-04, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=584206, encodeId=9141584206fc, content=您好，这个杂志提交文章时需要上传原始数据吗 田田要学习 2019-11-17 发表:: 投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…田田要学习 2019-11-17 00:00:00 发表: 投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…, beContent=田田要学习 2019-11-17 发表:: 投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79075262635, createdName=1480676am48(暂无昵称), createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129105, encodeId=4d6a212910559, content=请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Fri Apr 28 20:58:27 CST 2023, time=2023-04-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=964554, encodeId=29fa9645544c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：一审40多天，返回大修；1个月后修回，送审1周多返回小修(一个很小的点)；二次修回又送审了，现在2周了，系统显著审稿结束1周多(Required Reviews Completed)，还没消息。感觉编辑处理速度比较慢，也没有像别人说的那样修回一两天就接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0765497914, createdName=牛奶味的果汁, createdTime=Tue May 11 12:47:36 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145528, encodeId=bbb0214552839, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：癌症;LncRNA;机制研究 经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e68203665, createdName=ms3000001479435505, createdTime=Thu Jun 29 21:02:28 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2093349, encodeId=4e632093349e1, content=请问一般with editor多久啊？都一周了还没有消息？会不会被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b058356108, createdName=ms1000000391690108, createdTime=Wed Oct 12 11:14:27 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095327, encodeId=7456209532ef1, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：生物信息学 经验分享：很好的投稿体验！主要是做公共单细胞数据库挖掘+不到1个figure的湿实验（组化+免疫荧光），审稿速度超快，9-18左右投稿，一周左右就送审了，10-8左右给的一审意见，隔了三天修回，第二天就给二审意见，补充了一个组化，10-20左右修回，10-22今天早上看就已经accept！祝大家投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da05572124, createdName=ms2000000321618143, createdTime=Sat Oct 22 09:29:14 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147806, encodeId=005b214e806e4, content=偏重的研究方向：心血管疾病 经验分享：这个杂志是不是 submit to the journal后立即就under review了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Thu Jul 13 10:13:14 CST 2023, time=2023-07-13, status=1, ipAttribution=首尔), GetPortalCommentsPageByObjectIdResponse(id=2128354, encodeId=f3c1212835411, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;信号通路 经验分享：这个期刊效率挺高的，3月4号投稿，29号收到小修意见，4月10号修回，4月23号接收。总体而言，投稿体验不错，效率快，审稿人和编辑也很n i c e。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd698523082, createdName=ms4000000431284905, createdTime=Wed Apr 26 01:20:31 CST 2023, time=2023-04-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2153895, encodeId=19632153895ba, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：耐药 经验分享：新鲜出炉的投稿数据分享： 6-20投稿， 6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修 8-08修回 8-21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Aug 21 17:00:18 CST 2023, time=2023-08-21, status=1, ipAttribution=广东省)]

2023-07-13 bana 来自首尔

偏重的研究方向：心血管疾病
经验分享：这个杂志是不是 submit to the journal后立即就under review了？

51 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166615, encodeId=9c21216661581, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：从投稿到接收一个月零一周效率很高了。两周返回一审意见十天修回修回后两周接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Sat Nov 04 09:45:15 CST 2023, time=2023-11-04, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=584206, encodeId=9141584206fc, content=您好，这个杂志提交文章时需要上传原始数据吗 田田要学习 2019-11-17 发表:: 投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…田田要学习 2019-11-17 00:00:00 发表: 投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…, beContent=田田要学习 2019-11-17 发表:: 投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79075262635, createdName=1480676am48(暂无昵称), createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129105, encodeId=4d6a212910559, content=请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Fri Apr 28 20:58:27 CST 2023, time=2023-04-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=964554, encodeId=29fa9645544c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：一审40多天，返回大修；1个月后修回，送审1周多返回小修(一个很小的点)；二次修回又送审了，现在2周了，系统显著审稿结束1周多(Required Reviews Completed)，还没消息。感觉编辑处理速度比较慢，也没有像别人说的那样修回一两天就接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0765497914, createdName=牛奶味的果汁, createdTime=Tue May 11 12:47:36 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145528, encodeId=bbb0214552839, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：癌症;LncRNA;机制研究 经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e68203665, createdName=ms3000001479435505, createdTime=Thu Jun 29 21:02:28 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2093349, encodeId=4e632093349e1, content=请问一般with editor多久啊？都一周了还没有消息？会不会被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b058356108, createdName=ms1000000391690108, createdTime=Wed Oct 12 11:14:27 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095327, encodeId=7456209532ef1, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：生物信息学 经验分享：很好的投稿体验！主要是做公共单细胞数据库挖掘+不到1个figure的湿实验（组化+免疫荧光），审稿速度超快，9-18左右投稿，一周左右就送审了，10-8左右给的一审意见，隔了三天修回，第二天就给二审意见，补充了一个组化，10-20左右修回，10-22今天早上看就已经accept！祝大家投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da05572124, createdName=ms2000000321618143, createdTime=Sat Oct 22 09:29:14 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147806, encodeId=005b214e806e4, content=偏重的研究方向：心血管疾病 经验分享：这个杂志是不是 submit to the journal后立即就under review了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Thu Jul 13 10:13:14 CST 2023, time=2023-07-13, status=1, ipAttribution=首尔), GetPortalCommentsPageByObjectIdResponse(id=2128354, encodeId=f3c1212835411, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;信号通路 经验分享：这个期刊效率挺高的，3月4号投稿，29号收到小修意见，4月10号修回，4月23号接收。总体而言，投稿体验不错，效率快，审稿人和编辑也很n i c e。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd698523082, createdName=ms4000000431284905, createdTime=Wed Apr 26 01:20:31 CST 2023, time=2023-04-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2153895, encodeId=19632153895ba, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：耐药 经验分享：新鲜出炉的投稿数据分享： 6-20投稿， 6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修 8-08修回 8-21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Aug 21 17:00:18 CST 2023, time=2023-08-21, status=1, ipAttribution=广东省)]

2023-04-26 ms4000000431284905 来自重庆

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤;信号通路
经验分享：这个期刊效率挺高的，3月4号投稿，29号收到小修意见，4月10号修回，4月23号接收。总体而言，投稿体验不错，效率快，审稿人和编辑也很n i c e。

52 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166615, encodeId=9c21216661581, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：从投稿到接收一个月零一周效率很高了。两周返回一审意见十天修回修回后两周接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Sat Nov 04 09:45:15 CST 2023, time=2023-11-04, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=584206, encodeId=9141584206fc, content=您好，这个杂志提交文章时需要上传原始数据吗 田田要学习 2019-11-17 发表:: 投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…田田要学习 2019-11-17 00:00:00 发表: 投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…, beContent=田田要学习 2019-11-17 发表:: 投了两天到三天…说你的文章不适合我们…嗯…倒是也挺快的…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79075262635, createdName=1480676am48(暂无昵称), createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129105, encodeId=4d6a212910559, content=请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Fri Apr 28 20:58:27 CST 2023, time=2023-04-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=964554, encodeId=29fa9645544c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：一审40多天，返回大修；1个月后修回，送审1周多返回小修(一个很小的点)；二次修回又送审了，现在2周了，系统显著审稿结束1周多(Required Reviews Completed)，还没消息。感觉编辑处理速度比较慢，也没有像别人说的那样修回一两天就接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0765497914, createdName=牛奶味的果汁, createdTime=Tue May 11 12:47:36 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145528, encodeId=bbb0214552839, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：癌症;LncRNA;机制研究 经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e68203665, createdName=ms3000001479435505, createdTime=Thu Jun 29 21:02:28 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2093349, encodeId=4e632093349e1, content=请问一般with editor多久啊？都一周了还没有消息？会不会被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b058356108, createdName=ms1000000391690108, createdTime=Wed Oct 12 11:14:27 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095327, encodeId=7456209532ef1, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：生物信息学 经验分享：很好的投稿体验！主要是做公共单细胞数据库挖掘+不到1个figure的湿实验（组化+免疫荧光），审稿速度超快，9-18左右投稿，一周左右就送审了，10-8左右给的一审意见，隔了三天修回，第二天就给二审意见，补充了一个组化，10-20左右修回，10-22今天早上看就已经accept！祝大家投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da05572124, createdName=ms2000000321618143, createdTime=Sat Oct 22 09:29:14 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147806, encodeId=005b214e806e4, content=偏重的研究方向：心血管疾病 经验分享：这个杂志是不是 submit to the journal后立即就under review了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Thu Jul 13 10:13:14 CST 2023, time=2023-07-13, status=1, ipAttribution=首尔), GetPortalCommentsPageByObjectIdResponse(id=2128354, encodeId=f3c1212835411, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;信号通路 经验分享：这个期刊效率挺高的，3月4号投稿，29号收到小修意见，4月10号修回，4月23号接收。总体而言，投稿体验不错，效率快，审稿人和编辑也很n i c e。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd698523082, createdName=ms4000000431284905, createdTime=Wed Apr 26 01:20:31 CST 2023, time=2023-04-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2153895, encodeId=19632153895ba, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：耐药 经验分享：新鲜出炉的投稿数据分享： 6-20投稿， 6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修 8-08修回 8-21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Aug 21 17:00:18 CST 2023, time=2023-08-21, status=1, ipAttribution=广东省)]

2023-08-21 1891e859aem 来自广东省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：耐药
经验分享：新鲜出炉的投稿数据分享：
6-20投稿，
6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修
8-08修回
8-21接收

44 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务